Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21237715 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Condition: Malaria
Interventions: Biological: R21/Matrix-M1;   Other: Saline
2 Completed Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.
Condition: Malaria
Interventions: Biological: GSK malaria vaccine 257049 Vaccine;   Biological: Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine

Indicates status has not been verified in more than two years